世界の甲状腺疾患の診断と治療市場

本レポートは、甲状腺疾患の診断および治療における世界市場の動向を分析しています。本レポートには、2024年を基準年とする世界市場における売上高（百万ドル）、2025年の推定データ、そして2026年から2030年の予測期間が含まれています。市場は、疾患の種類、製品の種類、エンドユーザー、地域別にセグメント化されています。疾患の種類は、甲状腺機能低下症、甲状腺機能亢進症、甲状腺がん、その他に分類されています。製品の種類は診断と治療です。診断市場は、診断検査、血液検査、画像検査に分類されています。治療市場は、薬物療法、甲状腺手術、甲状腺眼症（TED）治療に分類されており、その他のエンドユーザーは、病院、専門クリニック、小売薬局およびオンライン薬局、研究機関および学術機関、患者および在宅ケア施設です。対象となる地域は、北米、ヨーロッパ、アジア太平洋、その他の地域です。北米には、米国、カナダ、メキシコが含まれます。ヨーロッパには、ドイツ、英国、イタリア、フランス、スペイン、その他のヨーロッパが含まれます。アジア太平洋には、中国、日本、インド、韓国、その他のアジア太平洋地域が含まれます。

Report Highlights

The global market for diagnostics and treatment of thyroid gland disorders was valued at $15.5 billion in 2024 and is estimated to increase from $16.3 billion in 2025 to reach $21.0 billion by 2030, at a compound annual growth rate (CAGR) of 5.2% from 2025 through 2030.

甲状腺疾患の診断および治療の世界市場は、2024年に155億ドルと評価され、2025年から2030年にかけて5.2%の年平均成長率（CAGR）で増加し、2025年の163億ドルから2030年には210億ドルに達すると予測されています。

Report Scope

The report analyzes trends in the global market for diagnostics and treatment of thyroid gland disorders. The report includes global revenue ($ million) for the base year 2024, estimated data for 2025, and for the forecast period of 2026 through 2030. The market is segmented by type of disease, product type, end user and region. The disease types are segmented into hypothyroidism, hyperthyroidism, thyroid cancer, and others. Product types are diagnostics and treatments. The diagnostics market is segmented into diagnostic, blood and imaging tests. The treatment market is segmented into medication, thyroid surgery, thyroid eye disease (TED) treatment and other end users are hospitals, specialty clinics, retail and online pharmacies, research and academic institutions, and patient and home care settings. The regions covered are North America, Europe, Asia-Pacific, and the Rest of the World (RoW. North American consists of the U.S., Canada, and Mexico. Europe includes Germany, the U.K., Italy, France, Spain and the Rest of Europe. Asia-Pacific includes China, Japan, India, South Korea and the Rest of Asia-Pacific.

This report focuses on trends and challenges that affect the market, including emerging technologies. It includes an analysis of the competitive landscape, with the rankings and market shares of the leading companies in the global market. The report has a chapter on environmental, social, and corporate governance (ESG) developments and includes company profiles that covers key financials, product portfolios and recent news.

Report Synopsis

Report Includes

– 97 data tables and 62 additional tables

– An overview of the current and future global markets for thyroid gland disorder

– An analysis of the global market trends with market revenue data from 2022 to 2024, estimates for 2025, and projected CAGRs through 2030

– Estimates of the size and revenue prospects of the global market, along with a market share analysis by type, disease type, end-user industry, and region

– Facts and figures pertaining to market dynamics, technological advances, regulations, and the impact of macroeconomic factors

– Analysis of market opportunities from a Porter’s Five Forces perspective, and a value chain analysis considering the prevailing micro- and macro environmental factors

– Coverage of advances in thyroid cancer diagnosis such as genomic tests and treatments, as well as the side effects of current treatments such as radioactive iodine

– Evaluation of ESG practices in the industry, consumer attitudes towards sustainability, risks and opportunity assessment, ratings and matrices

– A patent analysis with emphasis on emerging technologies and new developments in the market

– Analysis of the industry structure, including companies’ market shares and rankings, strategic alliances, M&A activity and a venture funding outlook

– Company profiles of major players within the industry, including Amgen Inc., F. Hoffmann-La Roche Ltd., Merck KGaA, Bristol-Myers Squibb Co., and Pfizer Inc.

Table of Contents

Chapter 1 Executive Summary

Market Outlook

Scope of Report

Market Summary

Chapter 2 Market Overview

Overview

Conventional and Novel Technologies

Diagnostics in Thyroid Gland Disorders

Treatment of Thyroid Gland Disorders

Porter’s Five Forces Analysis

Potential for New Entrants (Moderate)

Bargaining Power of Suppliers (Moderate to High)

Bargaining Power of Buyers (Moderate to High)

Threat of Substitutes (Low to Moderate)

Industry Competitiveness (High)

Macroeconomic Factors

Aging Population

Regulatory Environment

Growing Incidence of Cancer

Government Policy and Collaboration

Chapter 3 Market Dynamics

Market Drivers

Growing Prevalence of Thyroid Cancer

Growing Prevalence of Thyroid Disorders

Rising Awareness and Policy Initiatives for Thyroid Disorders

Managing Thyroid Disorders through Personalized Medicine

Market Restraints

Side Effects of Treatment

Limited Access in Low-Income Regions

Market Opportunities

Incorporation of AI

Advanced Therapeutics

Market Challenges

Healthcare Disparities and Funding Challenges

Requirement for Lifelong Medication

Chapter 4 Regulatory Landscape

U.S. Approval Process

EU Approval Process

Asia-Pacific Approval Process

Drug Approval and Regulations

Levothyroxine-Based Treatments

Anti-Thyroid Medications

Biologic and Biosimilar Regulations

Medical Devices and Diagnostics Regulations

Point-of-Care and Laboratory Tests

Wearable and Digital Health Solutions

Future Trends and Regulatory Changes

Chapter 5 Emerging Technologies and Developments

Overview

Emerging Technologies in Thyroid Disorder Diagnostics

Hybrid Feature Selection and Deep Learning Framework

Autofluorescence Technology for Thyroid and Parathyroid Surgery

Regenerative Medicine and Bioengineering

Biowearable Technology

Mobile Apps

Recent Approvals and Launches of Drug and Device Products

Patent Analysis

Findings

Chapter 6 Market Segmentation Analysis

Segmentation Breakdown

Key Takeaways

Market Analysis by Disease Type

Hypothyroidism

Hyperthyroidism

Thyroid Cancer

Other Diseases

Market Analysis by Type

Takeaways

Diagnostics

Treatment

Market Analysis by End User

Takeaways

Treatment in Hospitals and Specialty Clinics

Retail and Online Pharmacies

Research and Academic Institutes

Home Care Settings

Geographic Breakdown

Market Analysis by Region

Takeaways

North America

Europe

Asia-Pacific

South America

Middle East and Africa

Chapter 7 Competitive Intelligence

Takeaways

Market Shares of Leading Companies

Developments and Strategies

Agreements, Collaborations and Partnerships

Acquisitions

Chapter 8 Sustainability in the Diagnostics and Treatment of Thyroid Gland Disorders Industry: ESG Perspective

Introduction to ESG

Initiatives by Leading Companies

ESG Risk Ratings

BCC Research Viewpoint

Chapter 9 Appendix

Research Methodology

Sources

Abbreviations

Company Profiles

ABBOTT

ABBVIE INC.

AMGEN INC.

ASTRAZENECA

BRISTOL-MYERS SQUIBB CO.

HOFFMANN-LA ROCHE LTD.

FRESENIUS SE & CO. KGAA

GSK PLC.

LILLY

MERCK KGAA

NOVARTIS AG

PFIZER INC.

SANOFI

SIEMENS HEALTHINEERS AG

TERUMO CORP.

Emerging Start-ups/ Market Disruptors

List of Tables

Summary Table : Global Market for Diagnostics and Treatment of Thyroid Gland Disorders, by Region, Through 2030

Table 1 : Incidence of Thyroid Cancer in 2022

Table 2 : Hypothyroidism Prevalence in the U.S. based on Optum Administrative Claims Database, 2012-2019

Table 3 : Guidelines on Diagnosis and Management of Genetic Disorders of Thyroid Hormone, European Thyroid Association, 2024

Table 4 : Comparative of HFSDLF Framework and Other Approaches, 2025

Table 5 : Published Patents on Thyroid Gland Disorders: Diagnostics and Treatment, January 2024–January 2025

Table 6 : Global Market for Diagnostics and Treatment of Thyroid Gland Disorders, by Disease, Through 2030

Table 7 : Global Market for Diagnostics and Treatment of Hypothyroidism, by Region, Through 2030

Table 8 : Global Market for Diagnostics and Treatment of Hyperthyroidism, by Region, Through 2030

Table 9 : FDA-Approved Drugs in Advanced RR-DTC, 2025

Table 10 : Tyrosine Kinase Inhibitors Tested in Thyroid Cancers, 2025

Table 11 : Global Market for Diagnostics and Treatment of Thyroid Cancer, by Region, Through 2030

Table 12 : Global Market for Diagnostics and Treatment of Other Thyroid Gland Disorders, by Region, Through 2030

Table 13 : Global Market for Diagnostics and Treatment of Thyroid Gland Disorders, by Type, Through 2030

Table 14 : Global Market for Diagnostics of Thyroid Gland Disorders, by Region, Through 2030

Table 15 : Global Market for Diagnostics of Thyroid Gland Disorders, by Type, Through 2030

Table 16 : Global Market for Blood Test Diagnostics of Thyroid Gland Disorders, by Region, Through 2030

Table 17 : Global Market for Imaging Diagnostic Tests of Thyroid Gland Disorders, by Region, Through 2030

Table 18 : Global Market for Treatment of Thyroid Gland Disorders, by Region, Through 2030

Table 19 : Global Market for Treatment of Thyroid Gland Disorders, by Type, Through 2030

Table 20 : Global Market for Medication Treatment of Thyroid Gland Disorders, by Region, Through 2030

Table 21 : Global Market for Thyroid Surgery, by Region, Through 2030

Table 22 : Biologics in the Pipeline for Potential Use in the Treatment of TED, 2025

Table 23 : Global Market for the Treatment of TED, by Region, Through 2030

Table 24 : Global Market for RAI Treatment of Thyroid Gland Disorders, by Region, Through 2030

Table 25 : Global Market for Other Treatments of Thyroid Gland Disorders, by Region, Through 2030

Table 26 : Global Market for Diagnostics and Treatment of Thyroid Gland Disorders, by End User, Through 2030

Table 27 : Global Market for Diagnostics and Treatment of Thyroid Gland Disorders in Hospitals and Specialty Clinics, by Region, Through 2030

Table 28 : Global Market for Diagnostics and Treatment of Thyroid Gland Disorders in Retail and Online Pharmacies, by Region, Through 2030

Table 29 : Global Market for Diagnostics and Treatment of Thyroid Gland Disorders in Research and Academic Institutes, by Region, Through 2030

Table 30 : Global Market for Diagnostics and Treatment of Thyroid Gland Disorders in Home Care Settings, by Region, Through 2030

Table 31 : Global Market for Diagnostics and Treatment of Thyroid Gland Disorders, by Region, Through 2030

Table 32 : North American Market for Diagnostics and Treatment of Thyroid Gland Disorders, by Disease, Through 2030

Table 33 : North American Market for Diagnostics and Treatment of Thyroid Gland Disorders, by Type, Through 2030

Table 34 : North American Market for Diagnostics and Treatment of Thyroid Gland Disorders, by Diagnostics, Through 2030

Table 35 : North American Market for Diagnostics and Treatment of Thyroid Gland Disorders, by Treatment, Through 2030

Table 36 : North American Market for Diagnostics and Treatment of Thyroid Gland Disorders, by End User, Through 2030

Table 37 : North American Market for Diagnostics and Treatment of Thyroid Gland Disorders, by Country, Through 2030

Table 38 : U.S. Market for Diagnostics and Treatment of Thyroid Gland Disorders, by Disease, Through 2030

Table 39 : U.S. Market for Diagnostics and Treatment of Thyroid Gland Disorders, by Type, Through 2030

Table 40 : Canadian Market for Diagnostics and Treatment of Thyroid Gland Disorders, by Disease, Through 2030

Table 41 : Canadian Market for Diagnostics and Treatment of Thyroid Gland Disorders, by Type, Through 2030

Table 42 : Mexican Market for Diagnostics and Treatment of Thyroid Gland Disorders, by Disease, Through 2030

Table 43 : Mexican Market for Diagnostics and Treatment of Thyroid Gland Disorders, by Type, Through 2030

Table 44 : Demographic Patterns in Thyroid Medication Use per 10,000 Population in European Countries, 2022

Table 45 : European Market for Diagnostics and Treatment of Thyroid Gland Disorders, by Disease, Through 2030

Table 46 : European Market for Diagnostics and Treatment of Thyroid Gland Disorders, by Type, Through 2030

Table 47 : European Market for Diagnostics and Treatment of Thyroid Gland Disorders, by Diagnostics, Through 2030

Table 48 : European Market for Diagnostics and Treatment of Thyroid Gland Disorders, by Treatment, Through 2030

Table 49 : European Market for Diagnostics and Treatment of Thyroid Gland Disorders, by End User, Through 2030

Table 50 : European Market for Diagnostics and Treatment of Thyroid Gland Disorders, by Country, Through 2030

Table 51 : U.K. Market for Diagnostics and Treatment of Thyroid Gland Disorders, by Disease, Through 2030

Table 52 : U.K. Market for Diagnostics and Treatment of Thyroid Gland Disorders, by Type, Through 2030

Table 53 : French Market for Diagnostics and Treatment of Thyroid Gland Disorders, by Disease, Through 2030

Table 54 : French Market for Diagnostics and Treatment of Thyroid Gland Disorders, by Type, Through 2030

Table 55 : Italian Market for Diagnostics and Treatment of Thyroid Gland Disorders, by Disease, Through 2030

Table 56 : Italian Market for Diagnostics and Treatment of Thyroid Gland Disorders, by Type, Through 2030

Table 57 : German Market for Diagnostics and Treatment of Thyroid Gland Disorders, by Disease, Through 2030

Table 58 : German Market for Diagnostics and Treatment of Thyroid Gland Disorders, by Type, Through 2030

Table 59 : Spanish Market for Diagnostics and Treatment of Thyroid Gland Disorders, by Disease, Through 2030

Table 60 : Spanish Market for Diagnostics and Treatment of Thyroid Gland Disorders, by Type, Through 2030

Table 61 : Rest of European Market for Diagnostics and Treatment of Thyroid Gland Disorders, by Disease, Through 2030

Table 62 : Rest of European Market for Diagnostics and Treatment of Thyroid Gland Disorders, by Type, Through 2030

Table 63 : Asia-Pacific Market for Diagnostics and Treatment of Thyroid Gland Disorder, by Disease, Through 2030

Table 64 : Asia-Pacific Market for Diagnostics and Treatment of Thyroid Gland Disorders, by Type, Through 2030

Table 65 : Asia-Pacific Market for Diagnostics and Treatment of Thyroid Gland Disorders, by Diagnostics, Through 2030

Table 66 : Asia-Pacific Market for Diagnostics and Treatment of Thyroid Gland Disorders, by Treatment, Through 2030

Table 67 : Asia-Pacific Market for Diagnostics and Treatment of Thyroid Gland Disorders, by End User, Through 2030

Table 68 : Asia-Pacific Market for Diagnostics and Treatment of Thyroid Gland Disorders, by Country, Through 2030

Table 69 : Chinese Market for Diagnostics and Treatment of Thyroid Gland Disorders, by Disease Type, Through 2030

Table 70 : Chinese Market for Diagnostics and Treatment of Thyroid Gland Disorders, by Type, Through 2030

Table 71 : Indian Market for Diagnostics and Treatment of Thyroid Gland Disorders, by Disease, Through 2030

Table 72 : Indian Market for Diagnostics and Treatment of Thyroid Gland Disorders, by Type, Through 2030

Table 73 : Japanese Market for Diagnostics and Treatment of Thyroid Gland Disorders, by Disease, Through 2030

Table 74 : Japanese Market for Diagnostics and Treatment of Thyroid Gland Disorders, by Type, Through 2030

Table 75 : Australian Market for Diagnostics and Treatment of Thyroid Gland Disorders, by Disease, Through 2030

Table 76 : Australian Market for Diagnostics and Treatment of Thyroid Gland Disorders, by Type, Through 2030

Table 77 : South Korean Market for Diagnostics and Treatment of Thyroid Gland Disorders, by Disease, Through 2030

Table 78 : South Korean Market for Diagnostics and Treatment of Thyroid Gland Disorders, by Type, Through 2030

Table 79 : Rest of Asia-Pacific Market for Diagnostics and Treatment of Thyroid Gland Disorders, by Disease, Through 2030

Table 80 : Rest of Asia-Pacific Market for Diagnostics and Treatment of Thyroid Gland Disorders, by Type, Through 2030

Table 81 : South American Market for Diagnostics and Treatment of Thyroid Gland Disorders, by Disease, Through 2030

Table 82 : South American Market for Diagnostics and Treatment of Thyroid Gland Disorders, by Type, Through 2030

Table 83 : South American Market for Diagnostics and Treatment of Thyroid Gland Disorders, by Diagnostics, Through 2030

Table 84 : South American Market for Diagnostics and Treatment of Thyroid Gland Disorders, by Treatment, Through 2030

Table 85 : South American Market for Diagnostics and Treatment of Thyroid Gland Disorders, by End User, Through 2030

Table 86 : MEA Market for Diagnostics and Treatment of Thyroid Gland Disorders, by Disease, Through 2030

Table 87 : MEA Market for Diagnostics and Treatment of Thyroid Gland Disorders, by Type, Through 2030

Table 88 : MEA Market for Diagnostics and Treatment of Thyroid Gland Disorders, by Diagnostics, Through 2030

Table 89 : MEA Market for Diagnostics and Treatment of Thyroid Gland Disorders, by Treatment, Through 2030

Table 90 : MEA Market for Diagnostics and Treatment of Thyroid Gland Disorders, by End User, Through 2030

Table 91 : Leading Companies in the Market, 2024

Table 92 : Agreements, Collaborations and Partnerships in the Diagnostics and Treatment of Thyroid Gland Disorder Industry, 2021-2025

Table 93 : Acquisitions in the Diagnostics and Treatment for Thyroid Gland Disorder Industry, 2023-2024

Table 94 : ESG Highlights, by Leading Companies, 2023 and 2024

Table 95 : ESG Risk Rankings, 2024

Table 96 : Report Information Sources

Table 97 : Abbreviations Used in this Report

Table 98 : Abbott: Company Snapshot

Table 99 : Abbott: Financial Performance, FY 2023 and 2024

Table 100 : Abbott: Product Portfolio

Table 101 : Abbott: News/Key Developments 2023-2025

Table 102 : AbbVie Inc.: Company Snapshot

Table 103 : AbbVie Inc.: Financial Performance, FY 2023 and 2024

Table 104 : AbbVie Inc.: Product Portfolio

Table 105 : AbbVie Inc.: News/Key Developments, 2023 and 2024

Table 106 : Amgen Inc.: Company Snapshot

Table 107 : Amgen Inc.: Financial Performance, FY 2023 and 2024

Table 108 : Amgen Inc.: Product Portfolio

Table 109 : Amgen Inc.: News/Key Developments, 2021-2024

Table 110 : AstraZeneca: Company Snapshot

Table 111 : AstraZeneca: Financial Performance, FY 2023 and 2024

Table 112 : AstraZeneca: Product Portfolio

Table 113 : AstraZeneca: News/Key Developments, 2021−2024

Table 114 : Bristol-Myers Squibb Co.: Company Snapshot

Table 115 : Bristol-Myers Squibb Co.: Financial Performance, FY 2023 and 2024

Table 116 : Bristol-Myers Squibb Co.: Product Portfolio

Table 117 : Bristol-Myers Squibb Co.: News/Key Developments, 2023–2025

Table 118 : F. Hoffmann-La Roche Ltd.: Company Snapshot

Table 119 : F. Hoffmann-La Roche Ltd.: Financial Performance, FY 2023 and 2024

Table 120 : F. Hoffmann-La Roche Ltd. : Product Portfolio

Table 121 : F. Hoffmann-La Roche Ltd.: News/Key Developments, 2022–2025

Table 122 : Fresenius SE & Co. KGaA: Company Snapshot

Table 123 : Fresenius SE & Co. KGaA: Financial Performance, FY 2023 and 2024

Table 124 : Fresenius SE & Co. KGaA: Product Portfolio

Table 125 : Fresenius SE & Co. KGaA: News/Key Developments, 2023 and 2024

Table 126 : GSK plc.: Company Snapshot

Table 127 : GSK plc.: Financial Performance, FY 2023 and 2024

Table 128 : GSK plc.: Product Portfolio

Table 129 : GSK plc.: News/Key Developments, 2021-2024

Table 130 : Lilly: Company Snapshot

Table 131 : Lilly: Financial Performance, FY 2023 and 2024

Table 132 : Lilly: Product Portfolio

Table 133 : Lilly: News/Key Developments, 2023 and 2024

Table 134 : Merck KGaA.: Company Snapshot

Table 135 : Merck KGaA.: Financial Performance, FY 2023 and 2024

Table 136 : Merck KGaA: Product Portfolio

Table 137 : Merck KGaA.: News/Key Developments, 2021-2023

Table 138 : Novartis AG: Company Snapshot

Table 139 : Novartis AG: Financial Performance, FY 2023 and 2024

Table 140 : Novartis AG: Product Portfolio

Table 141 : Novartis AG: News/Key Developments, 2022-2024

Table 142 : Pfizer Inc.: Company Snapshot

Table 143 : Pfizer Inc.: Financial Performance, FY 2023 and 2024

Table 144 : Pfizer Inc.: Product Portfolio

Table 145 : Pfizer Inc.: News/Key Developments, 2022–2024

Table 146 : Sanofi: Company Snapshot

Table 147 : Sanofi: Financial Performance, FY 2023 and 2024

Table 148 : Sanofi: Product Portfolio

Table 149 : Sanofi: News/Key Developments, 2022 and 2023

Table 150 : Siemens Healthineers AG: Company Snapshot

Table 151 : Siemens Healthineers AG: Financial Performance, FY 2023 and 2024

Table 152 : Siemens Healthineers AG: Product Portfolio

Table 153 : Siemens Healthineers AG: News/Key Developments, 2024

Table 154 : Terumo Corp.: Company Snapshot

Table 155 : Terumo Corp.: Financial Performance, FY 2022 and 2023

Table 156 : Terumo Corp.: Product Portfolio

Table 157 : Terumo Corp.: News/Key Developments, 2023

Table 158 : Emerging Startups

List of Figures

Summary Figure : Shares of Global Market for Diagnostics and Treatment of Thyroid Gland Disorders, by Region, 2024

Figure 1 : Existing and Emerging Technologies for the Treatment of Thyroid Disorders

Figure 2 : Porter’s Five Forces Market Analysis

Figure 3 : Market Dynamics of Thyroid Gland Disorders

Figure 4 : Shares of Global Thyroid Cancer Mortality in Males, by Region, 2022

Figure 5 : Thyroid Health Awareness in the Saudi Population: A Community Study

Figure 6 : Shares of Global Market for Diagnostics and Treatment of Thyroid Gland Disorders, by Disease, 2024

Figure 7 : Shares of Global Market for Diagnostics and Treatment of Thyroid Gland Disorders, by Type, 2024

Figure 8 : Shares of Global Market for Diagnostics of Thyroid Gland Disorders, by Type, 2024

Figure 9 : Shares of Global Market for Treatment of Thyroid Gland Disorders by Type, 2024

Figure 10 : Shares of Global Market for Diagnostics and Treatment of Thyroid Gland Disorders, by End User, 2024

Figure 11 : Shares of Global Market for Diagnostics and Treatment of Thyroid Gland Disorders, by Region, 2024

Figure 12 : North American Market Shares for Diagnostics and Treatment of Thyroid Gland Disorder, by Country, 2024

Figure 13 : European Market Shares for Diagnostics and Treatment of Thyroid Gland Disorders, by Country, 2024

Figure 14 : Asia-Pacific Market Shares for Diagnostics and Treatment of Thyroid Gland Disorders, by Country, 2024

Figure 15 : Shares for Companies in the Market for Diagnostics and Treatment of Thyroid Gland Disorders, 2024

Figure 16 : Abbott: Revenue Share, by Business Unit, FY 2024

Figure 17 : Abbott: Revenue Share, by Country/Region, FY 2024

Figure 18 : AbbVie Inc.: Revenue Share, by Business Unit, FY 2024

Figure 19 : AbbVie Inc.: Revenue Share, by Country/Region, FY 2024

Figure 20 : Amgen Inc.: Revenue Share, by Drug, FY 2024

Figure 21 : Amgen Inc.: Revenue Share, by Country/Region, FY 2024

Figure 22 : AstraZeneca: Revenue Share, by Business Unit, FY 2024

Figure 23 : AstraZeneca: Revenue Share, by Region/Country, FY 2024

Figure 24 : Bristol-Myers Squibb Co.: Revenue Share, by Business Unit, FY 2024

Figure 25 : Bristol-Myers Squibb Co.: Revenue Share, by Country/Region, FY 2024

Figure 26 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Business Unit, FY 2024

Figure 27 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Country/Region, FY 2024

Figure 28 : Fresenius SE & Co. KGaA: Revenue Share, by Business Unit, FY 2024

Figure 29 : Fresenius SE & Co. KGaA: Revenue Share, by Country/Region, FY 2024

Figure 30 : GSK plc.: Revenue Share, by Business Unit, FY 2024

Figure 31 : GSK plc.: Revenue Share, by Country/Region, FY 2024

Figure 32 : Lilly: Revenue Share, by Business Unit, FY 2024

Figure 33 : Lilly: Revenue Share, by Country/Region, FY 2024

Figure 34 : Merck KGaA: Revenue Share, by Business Unit, FY 2024

Figure 35 : Merck KGaA.: Revenue Share, by Country/Region, FY 2024

Figure 36 : Novartis AG: Revenue Share, by Business Unit, FY 2024

Figure 37 : Novartis AG: Revenue Share, by Country/Region, FY 2024

Figure 38 : Pfizer Inc.: Revenue Share, by Business Unit, FY 2024

Figure 39 : Pfizer Inc.: Revenue Share, by Country/Region, FY 2024

Figure 40 : Sanofi: Revenue Share, by Business Unit, FY 2024

Figure 41 : Sanofi: Revenue Share, by Country/Region, FY 2024

Figure 42 : Siemens Healthineers AG: Revenue Share, by Business Unit, FY 2024

Figure 43 : Siemens Healthineers AG: Revenue Share, by Country/Region, FY 2024

Figure 44 : Terumo Corp.: Revenue Share, by Business Unit, FY 2023

Figure 45 : Terumo Corp.: Revenue Share, by Country/Region, FY 2023

BCC Research（BCCリサーチ）はライフサイエンス、センサ、マテリアル、環境、商取引関連市場を中心とした広範な市場調査レポートを出版する米国の調査会社です。

ライセンス別価格表

2024年11月より価格構成が大幅に変更になりました。最新の価格についてはお問合せください。

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

新価格表

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

旧価格表

旧ライセンスタイプ1

旧ライセンスタイプ2

ご購入に関するご案内

価格・納期について

• 価格
• ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • 2-5ライセンス
    • 同一企業内5名までレポートファイルのご利用が可能です。
  • サイトライセンス
    • 同一企業同住所内でレポートファイルのご利用が可能です。
  • エンタープライズライセンス
    • 同一企業内人数無制限でレポートファイルのご利用が可能です。
• 納品形態
  • Eメール
• 納期
  • ご注文後3営業日以内

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

BCC Researchが出版する調査レポートのサンプルページのご依頼、見積り、ご質問など購入前のご相談はいつでもお気軽にご連絡ください。

最新調査レポート

• GCC地域における学術研究のコラボレーション 2025-06-27
• 量子コンピューティングの2030年までの技術と世界市場 2025-06-25
• 全ゲノムシーケンス(WGS)の世界市場 2025-06-25
• センサーの技術と世界市場 2025-06-24
• 難燃剤の技術と世界市場 2025-06-23

BCC Research  出版レポート一覧